Iomedico Ag
Clinical trials sponsored by Iomedico Ag, explained in plain language.
-
Real-Life check on promising myeloma drug combos
Disease control CompletedThis study observed adults with relapsed multiple myeloma who were already prescribed specific drug combinations in real-world clinics. Its main goal was to see how well patients stuck with their treatment plans and how the treatments affected their quality of life and disease co…
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated Apr 02, 2026 02:42 UTC
-
German study tracks advanced cancer Drug's Real-Life impact
Disease control CompletedThis study observed 10 patients in Germany with advanced gastrointestinal stromal tumors (GIST) who were already taking the drug ripretinib as part of their regular care. The goal was to collect real-world information on how the treatment affects patients' quality of life, how lo…
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Life quality tracked for frail leukemia patients on new drug combo
Disease control CompletedThis study observed how a specific drug combination affects the quality of life and daily reality for older adults with a certain type of acute myeloid leukemia (AML) who cannot tolerate standard chemotherapy. Researchers followed 8 patients in Germany to see how they felt and fu…
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Tracking a new drug Combo's Real-Life impact on advanced breast cancer
Disease control CompletedThis study observed how well a drug combination (tucatinib with trastuzumab and capecitabine) worked for 49 adults in Germany and Austria with advanced HER2-positive breast cancer that had worsened after at least two prior treatments. The main goal was to see how the treatment af…
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC